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Abstract
Background: Implementation is proposed to be a multiphase, multilevel process. After a period of exploration, an
adoption decision is made, typically at the upper management or policy level. Nevertheless, movement through
each of the subsequent phases of the implementation process involves clinicians or providers at the individual level
to adopt the innovation and then change their behavior to use/deliver the innovation. Multiple behavioral change
theories propose that intentions are a critical determinant of implementation behavior. However, there is a need for
the development and testing of pragmatic measures of providers’ intentions to use a specific innovation or
evidence-based practice (EBP).
Methods: Nine items were developed to assess providers’ intentions to use a specific innovation or EBP.
Motivational interviewing was the EBP in the study. Items were administered, as part of larger survey, to 179
providers across 38 substance use disorder treatment (SUDT) programs within five agencies in California, USA.
Rasch analysis was conducted using RUMM2030 software to assess the items, their overall fit to the Rasch
model, the response scale used, individual item fit, differential item functioning (DIF), and person separation.
Results: Following a stepwise process, the scale was reduced from nine items to three items to increase the
feasibility and acceptability of the scale while maintaining suitable psychometric properties. The three-item
unidimensional scale showed good person separation (PSI = .872), no disordering of thresholds, and no
evidence of uniform or non-uniform DIF. Rasch analysis supported the viability of the scale as a measure of
implementation intentions.
Conclusions: The Measure of Innovation-Specific Implementation Intentions (MISII) is a sound measure of providers’
intentions to use a specific innovation or EBP. Future evaluation of convergent, divergent, and predictive validity are
needed. The study also demonstrates the value of Rasch analysis for testing the psychometric properties of pragmatic
implementation measures.
Keywords: Implementation, Scale development, Rasch, Item response theory, Intentions, Social validity, Program
evaluation, Psychometrics, Process assessment, Diffusion of innovation
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Background
Delineating the mechanisms by which implementation
strategies work is not a simple task. Numerous factors,
distributed across levels of the outer system, local set-
ting, and inner organizational context, may influence an
implementation strategy’s mechanisms of action [1]. In
other words, the mechanisms by which implementation
strategies produce results may vary depending on the
context and the level of the underlying influences, po-
tentially including those at policy, organization, and/or
individual levels. It is therefore important to conduct im-
plementation research using implementation models
that hypothesize the direction and influences of such in-
fluencing factors (constructs). Subsequently, in order to
test these models and mechanisms, it is necessary to
have pragmatic, reliable, and valid tools to measure the
constructs [2].
Implementation is proposed to be a multilevel, multi-
phase process that involves policies, organizations, and
individual providers. In the present study we use the
term “provider” to refer to the individual person, such as
a clinician, who may or may not use an innovation in
practice [3, 4]. According to the Exploration, Prepar-
ation, Implementation, and Sustainment (EPIS) frame-
work, after development or discovery of an innovation, a
phase of exploration occurs, concluding with a decision
to either adopt or reject the given innovation. If the de-
cision is to adopt, a phase of preparation proceeds,
followed by providers beginning to use the innovation
(phase of operation/implementation) and ultimately in-
tegrating the innovation as routine (sustainment phase)
[3]. The adoption decision often is initiated at the
upper management or policy level. Yet, the movement
through each of the subsequent phases of the imple-
mentation process involves individual providers adopt-
ing and then using one or more specific innovations
or evidence-based practices (EBPs). Because providers
may not be involved in the adoption decision, it is
critical that, prior to preparation and implementation,
organizations understand providers’ attitudes toward
the selected innovation and their intentions to use it.
Behavioral change theories, such as the theory of
planned behavior [5] and the health belief model [6], posit
intentions as a determinant of behavior. In addition, the
construct of intentions has been conceptualized as a de-
terminant in implementation theories such as the diffu-
sion of innovations [7]. A systematic review of the
relationship between intention and behavior of clinicians
suggested a positive relationship between these variables
and highlighted the challenge of directly measuring behav-
ior [8], although the degree of concrete evidence of the re-
lationship is debated [8–10]. Techniques are being
developed and tested to improve intentions, including ac-
tion planning for innovations and specific implementation
strategies, to promote adoption and use of a given
innovation or practice (i.e., change behavior) [11]. In the
case of implementation, the sought-after provider behav-
ior is use of the innovation. Past research has supported
the relationship between attitudes towards the innovation
and such behaviors [12], and in line with theories of be-
havioral change, we expect that intentions will mediate
the relationship between innovation attitudes and partici-
pation in the implementation process. Determining pro-
viders’ intentions would be a useful proxy outcome with
several valuable functions including testing the hypotheses
of behavioral change theories, using in implementation
simulation studies, and facilitating the tailoring of imple-
mentation strategies depending on the measured inten-
tions level.
In 2016, an implementation measure for mental health
providers’ intentions to adopt EBP was developed and
tested [13]. Despite thorough design and sound psycho-
metric properties, there is a need for an intention meas-
ure for use in situations where the decision to adopt a
specific innovation or EBP is made at a separate level
(i.e., at the upper management or policy level) than
where it is being implemented (i.e., the provider level).
In addition, there are crucial distinctions between adopt-
ing and implementing evidence-based practice generally
(i.e., providers being willing to use any EBP) versus the
adoption and implementation of a specific practice.
Hence, consistent with the reasoning provided by Wil-
liams [13], there is need for an intentions scale that is
distinct from the adoption decision and that targets pro-
viders’ intentions to use a specific innovation. In
addition, the movement toward pragmatic measures that
are brief, have low burden, are sensitive to change, and
have broad applicability suggests the need for a measure
that can be tailored for any specific EBP or innovation
that is being implemented [2].
Improving the availability of measurement tools with
sound psychometric properties has been a priority in im-
plementation science for many years [14]. A number of
implementation measures have been developed and tested
using the classical test theory (CTT) standards of reliabil-
ity and validity [15, 16], often using factor analytic ap-
proaches in the process. Rasch measurement theory
(RMT) offers alternative methods for scale development
and evaluation. Both factor analysis and Rasch analysis are
classified as latent trait models; however, in the Rasch ap-
proach, responses to individual items may be used as indi-
cators of the latent variable, rather than relying on the
scale as a whole. In contrast to CTT, in which the focus is
on the correlations among the items, the RMT model fo-
cuses on the probability of individuals endorsing an item
given their responses to other items in the scale [17]. The
response to an item is an outcome of the linear probabilis-
tic association between a respondent’s “ability/severity/
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level” and an item’s “difficulty.” The Rasch model uses
a probabilistic Guttmann pattern whereby a hierarch-
ical ordering of items is predicted, such that the
probably to endorse higher on the rating scale to an
easy item will be greater than the probability to re-
spond higher to a harder item [18]. The probability
of a certain response to an item is a “logistic function
of the difference between the person’s level of, for ex-
ample pain, and the level of pain expressed by the
item, and only a function of that difference” [19].
RMT was developed within the educational sector, but
is now increasingly being used in other fields including
health services research [20, 21]. The Rasch model offers
some advantages for measure development and testing,
such as being able to assess the appropriateness of re-
sponse options; statistically and graphically evaluate the
targeting of the items to the sample; detect items, re-
spondents, or groups of respondents who do not fit the
model (e.g., lazy responders or biases for an item among
subgroups in the sample); and test the invariance of
items. As such, RMT should prove useful in developing
a measure of innovation-specific implementation
intentions.
The goal of this study was to develop and assess a
measure of intentions to use EBP that could be adapted
for use with specific EBPs, evidence-informed treat-
ments, or other innovations. To that end, we developed
and tested a provider-level measure of implementation
intention for a specific innovation using RMT and
methods.
Methods
Measure
The Measure of Innovation-Specific Implementation In-
tentions (MISII) was developed following the scale de-
velopment procedure described by DeVellis which
consists of (1) defining what is to be measured (i.e., the
construct/latent variable), (2) generating items and the
response format using an expert panel, (3) administering
items to a sample, and (4) evaluating items and optimiz-
ing the scale length [22]. This approach is also consistent
with the development of pragmatic measures and in par-
ticular having measures with good psychometric proper-
ties, high utility, and low burden for administration and
scoring.
We convened an expert panel to define the aspects of
the intentions construct and to develop items to tap
those aspects. The expert panel consisted of two clinical
psychologists and two industrial/organizational psychol-
ogists, all with extensive knowledge of implementation
science and behavioral theory. The aspects characterized
by the latent variable, intentions to use an innovation,
were considered, and group consensus identified them
as plans, desire, and scope. “Plans” pertain to the
behavioral aspect of intentions capturing the intensity
and definitive commitment a provider has to use the
innovation. “Desire” refers to the general motivation or
willingness a provider has to use the innovation. “Scope”
encapsulates the extent of the innovation a provider
aims to deliver. All aspects are thought to derive from
the latent variable and therefore to load on one factor,
representing a unidimensional latent construct and scale.
For each aspect, three items (see Table 1) were devel-
oped by the expert panel. A five-point Likert scale was
chosen for all items where respondents were instructed
to answer regarding the extent to which they intend to
use the innovation (motivational interviewing [MI]) on a
scale from 0 = not at all to 4 = to a very great extent.
Context
The study involved analysis of data collected as part of a
larger cluster randomized controlled trial of the Leader-
ship and Organizational Change for Implementation
(LOCI) implementation strategy [23]. The study was
conducted in substance abuse disorder treatment
(SUDT) agencies and clinics in California. The study
was approved by the University of California San Diego
ethics committee as well as the Los Angeles County and
San Diego County research ethics committees.
Participants
Participants for the present study were SUDT providers
delivering outpatient or residential services in Southern
California. Participants were 61.5% female, with a range
of educational levels: 14% master’s degree, 7.8% some
graduate work, 26.8% college graduate, 43.0% some col-
lege, 3.4% high school diploma, 3.4% General Equiva-
lency Diploma, and 0.6% no high school diploma.
Participants’ ethnicity were 36.0% Hispanic or Latino,
and race, 60.7% Caucasian, 19.7% Black or African
Table 1 Original measure of innovation-specific implementation
intentions
“Please answer the following questions about the extent to which you
intend to use Motivational Interviewing.”
1. I will consider using Motivational Interviewing with new clients. (b)
2. I plan to use Motivational Interviewing with my clients. (a)
3. I am going to apply my training in Motivational Interviewing to
address my clients’ needs. (a)
4. I intend to use Motivational Interviewing when appropriate for my
clients. (a)
5. Using Motivational Interviewing is a high priority for me. (b)
6. I strive to apply Motivational Interviewing principles in working with
my clients. (b)
7. I will use all aspects of Motivational Interviewing with my clients. (c)
8. I will use parts of Motivational Interviewing with my clients. (c)
9. I will use certain Motivational Interviewing strategies with my clients. (c)
The innovation for the study was Motivational Interviewing
Anchors for the scale were 0 = not at all, 1 = to a slight extent, 2 = to a
moderate extent, 3 = to a great extent, 4 = to a very great extent
The dimensions of the latent variable are indicated by (a) plans, (b) desire, and
(c) scope
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American, 5.1% American Indian or Alaskan Native,
1.7% Asian or Pacific Islander, 1.7% mixed, and 11.2%
other. At the time of survey completion, 66.7% of partic-
ipants were certified or licensed in the addictions field
and 12.4% were interns, while 20.3% were not certified
or licensed and 0.6% were previously, but not currently,
certified or licensed. Characteristics of participants are
provided in Table 2. In addition, data on prior to expos-
ure to MI was collected (see Table 3). As compensation
for their time completing the survey, participants re-
ceived a $25 gift card.
Procedures
At the beginning of the LOCI study, SUDT agency exec-
utives were approached by the research team to describe
and seek their participation in the LOCI study. Execu-
tives, wanting their agency to participate, identified and
informed and/or invited suitable work group supervisors
(e.g., based on program type, services provided, work
group structure) to participate. The research team then
followed up with supervisors to provide detailed infor-
mation about the project and for the research team to
further vet the specific clinic or work group. Once deter-
mined to fit, and supervisors agreed to participate, they
subsequently informed their SUDT providers about the
study and the opportunity to participate. Participants
had to be at least 18 years of age and employed at one of
the participating agencies. All participants were given
the opportunity to consent or decline participation in
the study as a whole, or to any component of the study.
Providers and supervisors received training in MI and
were expected to use MI where appropriate with their
clients. Provider participants were invited to complete
online surveys as part of the LOCI study. The intentions
to use MI items were administered at baseline to the
first LOCI cohort. In total, 179 substance use disorder
treatment (SUDT) providers across 38 SUDT programs
within five agencies in California, USA, responded to the
survey (86% response rate).
Data analyses
Data were screened by checking distributional character-
istics, the levels of missing data, and for out of range
values. Data were fitted to the Rasch-Andrich Rating
Scale Model for polytomous response scales [17, 24]
using RUMM2030 software [25]. To interpret the fit
statistic in Rasch analysis, it is recommended to have 10
Table 2 Participant characteristics
Characteristic n (%)
Gender
Male 68 (38.0%)
Female 110 (61.5%)
Age
≤ 41 years of age 58 (32.4%)
42–53 years of age 60 (33.5%)
≥ 54 years of age 50 (27.9%)
Ethnicity
Hispanic or Latino 64 (35.8%)
Race
Caucasian 108 (60.3%)
American Indian or Alaskan Native 9 (5.0%)
Asian or Pacific Islander 3 (1.7%)
Black or African American 35 (19.6%)
Other 20 (11.2%)
Mixed 3 (1.7%)
Education
No high school diploma 1 (0.6%)
General Educational Degree (GED) 6 (3.4%)
High school diploma 6 (3.4%)
Some college 77 (43.0%)
College graduate 48 (26.8%)
Some graduate work 14 (7.8%)
Master’s degree 25 (14.0%)
Addiction certification
Not currently certified or licensed 36 (20.1%)
Currently certified or licensed 118 (65.9%)
Previously certified or licensed 1 (0.6%)
Intern 22 (12.3%)
Table 3 Participant exposure to Motivational Interviewing
Characteristic n (%)
Trained in MI
Yes 132 (73.7%)
No 46 (25.7%)
When were you trained in MI?
In the past month 13 (7.3%)
In the past 6 months 26 (14.5%)
In the past year 33 (18.4%)
More than a year ago 60 (33.5%)
Unknown 47 (26.3%)
Degree of familiarity with MI principles
Not at all 6 (3.4%)
To a slight extent 28 (15.6%)
To a moderate extent 92 (51.4%)
To a great extent 42 (23.5%)
To a very great extent 10 (5.6%)
Are you currently using MI with clients?
Yes 141 (78.8%)
No 37 (20.7%)
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participants per item threshold [26], and therefore, 179
providers was an appropriate sample size for the final
scale of 3 items and 12 thresholds. Procedures followed
were consistent with key Rasch papers [18–20].
Internal consistency reliability of the scale was esti-
mated using the Person Separation Index (PSI), which
uses the evaluations of each respondents’ location on the
logit scale, rather than the raw score used in Cronbach’s
alpha to determine reliability [26]. Interpretation of the
PSI is equivalent to Cronbach’s alpha [19].
Three overall fit statistics were considered: two
item-person fit statistics and one item-trait interaction
statistic. Overall, fit is indicated by a non-significant
chi-square statistic (χ2) (p > 0.05 or 0.0056 with Bonfer-
roni adjustment [27]) and fit residual standard deviations
of less than 1.4 [28]. In addition, individual item and
person fit were determined by a significant χ2 statistic (p
< 0.05 or 0.0056 with Bonferroni adjustment), individual
fit residuals (between ± 2.5), and item characteristic
curves (ICCs). Residuals represent the standardized
summation of individual person and item deviations
from expected values [19]. ICCs visually indicate fit, in-
cluding under or over discrimination. A steeper ob-
served curve of respondents compared to the expected
model curve indicates over-discrimination and vice versa
[28]. In addition, the targeting of the items to the sample
was reviewed by assessing the mean location score of
respondents.
Sources of deviation from model expectation were an-
alyzed to see if the construction of the scale could be
improved, including making the scale more pragmatic
by reducing the number of items. A good fitting model
shows no disordered response thresholds and no differ-
ential item functioning (DIF) for any item. Assessing
DIF ensures different groups within the sample (e.g.,
males versus females or providers within the same
agency) did not respond differently to items despite hav-
ing the same level of intentions.
Finally, a test for violations of local independence (i.e.,
multidimensionality) was undertaken by a principal
component analysis (PCA) of the item residuals, using
the pairwise conditional maximum likelihood procedure
[26, 29]. A lack of pattern in the residuals supports the
assumption of local independence and thus unidimen-
sionality of the scale [30].
The psychometric properties of the scale were also an-
alyzed using common classical test theory methods, the
predominant methodology used for scale development
in the field of implementation science. Psychometric
properties of the scale were preliminarily evaluated using
the classical test theory. Reliability was assessed by
Cronbach’s alpha and construct validity by exploratory
factor analysis (EFA). Data was tested for suitability for
factor analysis by ensuring sample size of greater than
10 people per item [16, 31] and the strength of
inter-correlations using Bartlett’s test of sphericity [32],
Kaiser-Meyer-Olkin (KMO) measure of sampling
adequacy [33, 34], and individual measures of sampling
adequacy (MSA). Exploratory factor analysis was con-
ducted using principal axis factoring (PAF), with the
number of factors based on Kaiser Criterion, Catell’s
scree test, and Horn’s parallel analysis [35]. To allow for
the possibility of correlations between factors, an oblique
rotation (Oblimin) was used.
Results
The data were verified as suitable for factor and Rasch
analysis. There was no missing data for any item, and the
minimum and maximum response options were endorsed
for all items. Each item had a minimum of one coefficient
in the correlation matrix above 0.3. Bartlett’s test of spher-
icity was statistically significant (p < 0.001), and the KMO
measure (0.885) and MSAs were above the recommended
cut-off values. Cronbach’s alpha of the full scale was 0.933,
indicating redundancy of items, and consideration should
be given to shorten the scale [22].
The full data set for the nine items were exported to
RUMM 2030 for Rasch analysis. The scale showed very
good internal consistency with a PSI of 0.891 or 0.898
with extremes included (people that responded all 0 or
all 4) [22]. The total chi-square item-trait interaction
statistic (35.9674) was significant (p < 0.05 or 0.0056 with
Bonferroni adjustment), and the fit residual standard de-
viations for items (2.438) and for persons (1.807)
exceeded the recommended value of 1.4, all indicating
misfit or deviation from the Rasch measurement model.
As per CTT preliminary assessment, evaluation of individ-
ual item fit revealed problems with items 8 and 9, which
had fit residuals above + 2.5 and a probability value less
than the adjusted alpha value (0.0056). Disordered thresh-
olds were not revealed indicating the suitability of the re-
sponse options. Examination of the ICCs indicated items
2 and 3 were very slightly over-discriminating while items
8 and 9 were under-discriminating. Inspection of individ-
ual person fit revealed six people with fit residuals greater
than + 2.5. In each case, responses to item 8 were 0, while
all other items were endorsed high. Other discrepancies
were seen with items 9, 4, and 6. Finally, the scale did not
meet the standards for unidimensionality with 7.82% of
cases having statistically different scores for the two sub-
tests of items.
To resolve issues with model fit, items 8 and 9 were
sequentially deleted based on their large fit residuals and
their large and significant chi-square statistics. The as-
pect of intentions covered in the items (scope) was cov-
ered in item 7; therefore, removal of the items would
not hinder measurement coverage of the latent variable.
After the removal of these two items, a unidimensional,
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seven-item scale resulted in an overall fit to the Rasch
model, aside from slight individual item misfit (individ-
ual item fit residual − 0.9, SD 3.023). To advance a more
pragmatic scale that would reduce burden, a stepwise
procedure of item removal was followed (Table 4). Item
removal was based on item fit, ensuring a distribution of
item difficulties across the latent trait continuum, and
ensuring measurement of all aspects of intentions were
maintained (Table 5). The targeting map illustrated the
items, and thresholds spanned the range of person
scores (Fig. 1).
The final solution was a three-item scale (Table 6) with
no misfit to the Rasch measurement model and a PSI of
0.872 (with extremes included), indicating very good in-
ternal consistency [22]. Correlation between items was
below 0.3 indicating there was no response dependency.
In addition, no uniform or non-uniform DIF was found
across SUDT agencies, teams, gender, race, ethnicity,
certification level, or degree of MI familiarity. Independ-
ent t tests comparing person trait estimates on the two
most divergent items (item 5 and item 7) showed a sig-
nificant difference (p < 0.05) in scores for only 8 of the
179 t tests (4.47%), providing support of the unidimen-
sionality of the scale [36].
EFA was used to examine the potential latent factor
structure represented in the data. The EFA was con-
ducted using PAF with correlated factors (oblique) rota-
tion and suggested a two-factor solution (7 items and 2
items), as did Catell’s scree plot and Horn’s parallel ana-
lysis. The two items in the second factor (items 8 and 9),
however, exhibited high collinearity (0.891), suggesting
high conceptual overlap. Item 9 was selected for removal
because of its higher mean value and lower standard
deviation compared to item 8. With removal of item 9,
a one-factor solution resulted and internal consistency
remained extremely high, with a Cronbach’s alpha of
0.935 and 67.07% of variance explained. There was
high correlation of item 2 with both item 1 (0.898)
and item 3 (0.905), indicating removal of one of the
items, as per RMT.
Following the RMT process, the psychometric proper-
ties of the resulting three-item scale, were evaluated by
CCT, which resulted in a Cronbach’s alpha for the scale
of 0.900 and 75.25% of variance in the data being
explained.
The sample data showed overall high intentions to im-
plement MI (mean person logit score of 3.074, SD
3.383) with responses skewed to higher response options
(Table 7). In total, 28 respondents were located at the
extreme of the scale, responding 4 (i.e., highest inten-
tions to use MI) to each item. One way analysis of vari-
ance (ANOVA) of total scores revealed a significant
effect between agencies (F(4, 174) = 3.35, p = 0.011) and
sexes (F(1, 176) = 10.37, p = 0.002) on the total intention
scores. Overall, male providers reported lower intentions
(mean total score = 2.081, SD 3.48, n = 68) than female
providers (mean total score of 3.718, SD 3.18, n = 110)
to use motivational interviewing.
Discussion
The objective of this paper was to develop and examine
psychometric characteristics of a brief and pragmatic
measurement instrument to assess an individual provi-
der's intentions to implement a specific innovation. The
study resulted in the three-item MISII with one item
covering each of the three aspects of intentions: plans,
desire, and scope. The unidimensional scale fit the Rasch
model and showed good reliability with no disordered
thresholds or differential item functioning.
The development of a measure of an individual’s in-
tentions to implement an innovation is important as it
provides an easily measured proxy for the ultimate out-
come, behavioral change (i.e., use of the innovation). In
addition, the MISII will facilitate the examination of
mechanisms of behavior change such as those postulated
in the Theory or Planned Behavior [37]. For example,
such mechanisms may include antecedents including at-
titudes towards an EBP that in turn influence intentions
to use the EBP, which then predict subsequent behaviors
of adoption and use of the EBP.
Table 4 Summary of results of Rasch analysis of EBP-specific implementation intentions scale
Analysis Overall model fit Item fit residual mean (SD) Person fit residual mean (SD) PSIa % Sig. t testsb
1 Items 1–9 χ2 = 35.96, df = 9, p = 0.000 − 0.177 (2.438) − 0.843 (1.807) 0.898 7.82% CI: 0.046 to 0.110
2 Items 1–8 χ2 = 56.89, df = 8, p = 0.000 − 0.646 (3.186) − 0.701 (1.614) 0.898 8.38% CI: 0.052 to 0.116
3 Items 1–7 χ2 = 19.07, df = 7, p = 0.008 − 0.900 (3.023) − 0.739 (1.387) 0.909 5.59% CI: 0.024 to 0.088
4 Items 1–3, 5–7 χ2 = 7.50, df = 6, p = 0.277 − 0.879 (2.374) − 0.653 (1.209) 0.914 6.70% CI: 0.035 to 0.099
5 Items 1–2, 5–7 χ2 = 6.76, df = 5, p = 0.239 − 0.578 (1.766) − 0.619 (1.136) 0.895 6.70% CI: 0.035 to 0.099
6 Items 2, 5, 6, 7 χ2 = 3.20, df = 5, p = 0.526 − 0.372 (1.158) − 0.654 (1.100) 0.870 5.59% CI: 0.024 to 0.088
7 Items 2, 5, 7 χ2 = 2.38, df = 3, p = 0.497 − 0.136 (0.66) − 0.392 (0.73) 0.872 4.47%
SD standard deviation, χ2 chi-square, df degrees of freedom, p probability, PSI person separation index, CI confidence interval
aPSI with extremes included
bConfidence interval only reported if the % value exceeds 5%
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The MISII may be useful in many circumstances and
for multiple stakeholders of EBP implementation. Cur-
rently, upper level management in both the outer system
and inner organizational contexts may be unaware of
and thus pay little attention to providers’ intentions to
use an EBP prior to making an adoption decision. This
may be through the lack of understanding about the dif-
ficulty of implementing a new EBP, or the inability to
easily gauge intentions. Thus, there is potential for the
scale to be used to aid the adoption decision in strategic
implementation initiatives. This use is further facilitated
as it also fulfills multiple required pragmatic criteria of
being important to stakeholders, low in burden for re-
spondents and staff, actionable, and likely sensitive to
change. It is also consistent with additional recom-
mended criteria including being broadly applicable, un-
likely to cause harm, psychometrically strong, and
related to theories or models of implementation.
The scale is likely to be equally useful for outer and
inner context leaders, middle management, implementa-
tion facilitators, and implementation researchers who
all may use the results throughout the implementation
process to help select and tailor implementation strat-
egies in situations where organizations support or im-
pose the implementation of a specific EBP. For example,
an interesting result from the present study was the ana-
lysis of variance revealing that males had significantly
lower intentions to implement motivational interviewing
across all agencies. As such, gender-specific implementa-
tion strategies might be tailored to improve the
efficiency of implementation across providers [38]. As-
sessment using the MISII scale may also be used in
health care policy making to gauge the impact of policy
directives on clinicians and other service providers. Fur-
thermore, the MISII may be used to identify when and
where implementation policy initiatives are required, for
example, the provision of additional supports or imple-
mentation strategies if intentions are determined to be
low or sub-optimal. Further, the person location index
can identify individuals across the spectrum of low to
high intentions. Providers could therefore be segmented
into a number of groups depending on their location on
the scale to receive different implementation strategies
or different intensities of a strategy [39].
Items were created based on the knowledge and ex-
perience of a group of clinical and organizational psy-
chologists, all with significant (i.e., many years and
diverse range of clinical and organizational research ex-
perience) and relevant (i.e., investigators and clinicians
leading or involved in multiple implementation projects)
Table 5 Item location and threshold values (n = 150)
Item Location SE Residual DF Chi-square statistic DF Probability
2 − 1.030 0.166 − 0.696 96.33 7.569 2 0.023
5 0.608 0.156 − 0.301 96.33 4.849 2 0.088
7 0.423 0.157 0.590 96.33 2.484 2 0.289
Outliers/extreme cases n = 29 not included
No location values with significant deviations (p < 0.001), item fit residuals ±2.5, or reverse thresholds
Fig. 1 Targeting map for the three-item MISII (n = 179)
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implementation expertise. Ideally in RMT during the
qualitative stage, item difficulty would be considered in
the process, explicitly creating “easier” and more “diffi-
cult” items to cover the full range of the latent variable.
The final items of the scale showed fairly good spread
across the range of person logit scores of the sample.
Furthermore, it allowed for redundant items to be easily
removed without affecting the measurement of the la-
tent variable nor the validity of the scale. The resulting
scale retained three items, one covering each of the
three aspects of intentions.
Strengths and limitations
The MISII is the only implementation measure we are
aware of to be developed and tested using RMT (al-
though one study protocol has been published in which
RMT was proposed to measure stages of implementa-
tion completion [40]). In this study, the instrument was
provided to a group of SUDT providers asking about
their intentions to use MI. MI is a widely used EBP and
the majority of providers were familiar with, had re-
ceived some training in, and in many cases reportedly
were already using the technique to some degree. In
addition, for a number of respondents, it was known
that a policy level mandate on using MI was about to be
enacted. As such, a more diverse calibration sample and
assessment of the scale with individuals/providers from
other health and allied health sectors and disciplines,
and assessment of mechanisms, are recommended. For
example, indicators of provider fidelity to EBPs might
help to elucidate links between intentions and quality of
evidence-based practice use. Intentions to use an inter-
vention do not necessarily imply that the intent is to use
with a high level of fidelity. Indeed, for novices in MI,
there is likely some naiveté regarding what high quality
or expert delivery of MI entails. External validity of the
MISII scale may be enhanced by assessment of different
EBPs, different settings, and different demographic pro-
files of participants to increase the generalizability of the
scale.
Future research
We suggest future studies should examine convergent,
divergent, discriminant, and criterion-related (concur-
rent and predictive) validity of the scale to be conducted.
It may be possible to evaluate convergent validity with
other measures of intentions and divergent validity with
measures such as organizational climate, job satisfaction,
organizational commitment, and burnout. Discriminant
validity could be assessed by examining correlations with
measures of hypothesized non-related constructs. Criter-
ion validity of the MISII may be assessed by examining
uptake and use of an innovation such as the number of
training sessions attended or the degree to which the se-
lected innovation is used in a counseling session or clin-
ical encounter. Testing of sensitivity or responsiveness of
the scale would also be useful. This could occur by using
the scale in longitudinal studies at multiple time points
and/or before and after an implementation strategy is in
place. Finally, additional testing of the scale using other
innovations or EBPs is needed to demonstrate that the
measurement properties hold as the MISII is adapted for
other specific practices (e.g., cognitive-behavioral treat-
ment, clinical guidelines, exercise programs).
Conclusions
The Measure of Innovation-Specific Implementation In-
tentions (MISII) performed well based on both RMT
and CTT methods and is a reliable measure of providers’
intentions to use a specific EBP or new innovation. The
measure can be used in applied settings to better under-
stand and prepare for the implementation process and
in research settings to better understand the predictors
and outcomes of individuals’ implementation-related be-
havior. In addition, the study indicates the usefulness of
the Rasch method of analysis for testing the psychomet-
ric properties of implementation measures; future re-
search should continue to apply RMT techniques to
evaluate and develop measures of the implementation
process.
Table 6 Measure of Innovation-Specific Implementation Intentions (MISII)
Please answer the following questions about the extent to which you intend to use [EBP/innovation]
Not at all To a slight
extent
To a moderate
extent
To a great
extent
To a very great
extent
1 I plan to use [EBP/innovation] with my clients 0 1 2 3 4
2 Using [EBP/innovation] is a high priority for me 0 1 2 3 4
3 I will use all aspects of [EBP/innovation] with my clients 0 1 2 3 4
Table 7 Proportions of responses (valid percent) in all five
response categories (n = 150)
Item Response category
0 1 2 3 4
2 1 (0.67%) 10 (6.67%) 29 (19.33%) 78 (52.00%) 32 (21.33%)
5 3 (2.00%) 15 (10.00%) 58 (38.67%) 62 (41.33%) 12 (8.00%)
7 1 (0.67%) 19 (12.67%) 58 (38.67%) 62 (41.33%) 10 (6.67%)
Outliers/extreme cases n = 29 not included
Moullin et al. Implementation Science  (2018) 13:89 Page 8 of 10
Abbreviations
CTT: Classical test theory; DIF: Differential item functioning; EBP: Evidence-
based practice; EFA: Exploratory factor analysis; EPIS: Exploration, Preparation,
Implementation, and Sustainment; ICCs: Item characteristic curves;
KMO: Kaiser-Meyer-Olkin; LOCI: Leadership and Organizational Change for
Implementation; MI: Motivational interviewing; MISII: Measure of Innovation-
Specific Implementation Intentions; MSA: Measures of sampling adequacy;
PAF: Principle axis factoring; PCA: Principle components analysis; PSI: Person
Separation Index; RMT: Rasch measurement theory; SUDT: Substance use
disorder treatment
Acknowledgements
The authors thank the community-based organizations, counselors, case
managers, and supervisors that made this work possible. In addition, the
authors thank Amy Green and Elisa Torres for their assistance in item
development, Natalie Finn and Chariz Siejo for organizing data collection, and
Marisa Sklar for managing the database.
Funding
The funding for this project is provided by the US National Institute on Drug
Abuse (NIDA) grant number R01DA038466. The opinions expressed herein
are the views of the authors and do not necessarily reflect the official policy
or position of the National Institute on Drug Abuse or any other part of the
US Department of Health and Human Services.
Availability of data and materials
The datasets generated and/or analyzed during the current study are not
publicly available due to privacy concerns but may be requested from the
project principle investigator (GAA) on reasonable request.
Authors’ contributions
JCM, GAA, and MGE conceptualized the construct. GAA and MGE were
involved in the development of the scale items. All authors were involved in
overseeing data collection and management. JCM conducted the data analyses
and drafted the manuscript. All authors reviewed and edited the manuscript. All
authors read and approved the final manuscript.
Ethics approval and consent to participate
This study was approved by the University of California, San Diego, Human
Research Protections Program (HRPP; Protocol 141134) and the Los Angeles
and San Diego County ethics approval committees. Informed consent was
obtained from all participants.
Consent for publication
Not applicable.
Competing interests
GAA is an associate editor of Implementation Science; all decisions on this
paper were made by another editor. The authors declare that they have no
competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published
maps and institutional affiliations.
Author details
1Faculty of Health Sciences, School of Pharmacy and Biomedical Sciences,
Curtin University, Building 306, Kent Street, Bentley, Perth, Western Australia
6102, Australia. 2Child and Adolescent Services Research Center, 3665 Kearny
Villa Rd., Suite 200N, San Diego, CA 92123, USA. 3Department of Psychology,
University of Central Florida, Orlando, FL, USA. 4Department of Psychiatry,
University of California San Diego, San Diego, USA.
Received: 29 March 2018 Accepted: 19 June 2018
References
1. Brownson R, Colditz G, Proctor E, editors. Dissemination and
implementation research in health: translating science to practice. 2nd ed.
New York: Oxford University Press; 2018.
2. Glasgow RE. What does it mean to be pragmatic? Pragmatic methods,
measures, and models to facilitate research translation. Health Educ Behav.
2013;40:257–65.
3. Aarons G, Hurlburt M, Horwitz S. Advancing a conceptual model of
evidence-based practice implementation in public service sectors. Admin
Pol Ment Health. 2011;38:4–23.
4. Moullin J, Sabater-Hernández D, Fernandez-Llimos F, Benrimoj S. A
systematic review of implementation frameworks of innovations in
healthcare and resulting generic implementation framework. Health Res
Policy Syst. 2015;13:16.
5. Ajzen I. The theory of planned behaviour. Organ Behav Hum Decis Processs.
1991;50:179–211.
6. Rosenstock IM. Historical origins of the health belief model. Health Educ
Monogr. 1974;2:328–35.
7. Rogers EM. Diffusion of innovations. New York: Free Press; 2003. p. 5.
8. Eccles MP, Hrisos S, Francis J, Kaner EF, Dickinson HO, Beyer F, Johnston M.
Do self-reported intentions predict clinicians’ behaviour: a systematic
review. Implement Sci. 2006;1:28.
9. Sheeran P. Intention-behavior relations: a conceptual and empirical review.
Eur Rev Soc Psychol. 2002;12:1–36.
10. Hrisos S, Eccles MP, Francis JJ, Dickinson HO, Kaner EFS, Beyer F, Johnston
M. Are there valid proxy measures of clinical behaviour? A systematic
review. Implement Sci. 2009;4:37.
11. Hagger MS, Luszczynska A. Implementation intention and action planning
interventions in health contexts: state of the research and proposals for the
way forward. Appl Psychol Health Well-Being. 2014;6:1–47.
12. Ajzen I, Fishbein M. The influence of attitudes on behavior. In: Albarracín D,
Johnson BT, Zanna MP, editors. The handbook of attitudes. Abingdon:
Routledge; 2005. p. 173–221.
13. Williams N. Assessing mental health clinicians’ intentions to adopt evidence-
based treatments: reliability and validity testing of the evidence-based
treatment intentions scale. Implement Sci. 2016;11:60.
14. Lewis CC, Fischer S, Weiner BJ, Stanick C, Kim M, Martinez RG. Outcomes for
implementation science: an enhanced systematic review of instruments
using evidence-based rating criteria. Implement Sci. 2015;10:1–17.
15. Cronbach L. Coefficient alpha and the internal structure of tests.
Psychometrika. 1951;16:297–334.
16. Nunnally JC. Psychometric theory. 2nd ed. New York: McGraw-Hill; 1978.
17. Rasch G. Probabilistic models for some intelligence and attainment tests.
Chicago: University of Chicago Press; 1960.
18. Hagquist C, Bruce M, Gustavsson J. Using the Rasch model in nursing
research: an introduction and illustrative example. Int J Nurs Stud. 2009;46:
380–93.
19. Tennant A, Conaghan P. The Rasch measurement model in rheumatology:
what is it and why use it? When should it be applied, and what should one
look for in a Rasch paper. Arthritis Rheum. 2007;57:1358–62.
20. Pallant J, Tennant A. An introduction to the Rasch measurement model: an
example using the hospital anxiety and depression scale (HADS). Br J Clin
Psychol. 2007;46:1–18.
21. Engelhard G Jr. Invariant measurement: using Rasch models in the social,
behavioral and health sciences. New York: Routledge; 2013.
22. DeVellis RF. Scale development: theory and applications. 3rd ed. California:
Sage Publications; 2012.
23. Aarons GA, Ehrhart MG, Moullin JC, Torres EM, Green AE. Testing the
leadership and organizational change for implementation (LOCI)
intervention in substance abuse treatment: a cluster randomized trial study
protocol. Implement Sci. 2017;12:29.
24. Andrich D. Rating formulation for ordered response categories.
Psychometrika. 1978;43:561–73.
25. Andrich D, Lyne A, Sheridan B, Luo G. RUMM2030. Perth: RUMM
Laboratory; 2009.
26. Andrich D, Marais I. A course in Rasch measuremet theory. Perth: The
University of Western Australia; 2018.
27. Bland JM, Altman DG. Multiple significance tests: the Bonferroni method.
BMJ. 1995;310:170.
28. Pallant JF, Haines HM, Hildingsson I, Cross M, Rubertsson C. Psychometric
evaluation and refinement of the Prenatal Attachment Inventory. J Reprod
Infant Psychol. 2014;32:112–25.
29. Andrich D, Luo G. Conditional pairwise estimation in the Rasch model for
ordered response categories using principal components. J Appl Meas.
2003;4:205–21.
Moullin et al. Implementation Science  (2018) 13:89 Page 9 of 10
30. Smith EV Jr. Detecting and evaluation the impact of multidimensionality
using item fit statistics and principal component analysis of residuals. J Appl
Meas. 2002;3:205–31.
31. Tabachnick BG, Fidell LS. Using multivariate statistics. 5th ed. Boston:
Pearson; 2007.
32. Bartlett MS. A note on multiplying factors for various chi square
approximations. J R Stat Soc Series B Stat Methodol. 1954;16:296–8.
33. Kaiser HF. A second generation little jiffy. Psychometrika. 1970;35:401–15.
34. Kaiser HF. An index of factorial simplicity. Psychometrika. 1974;39:31–6.
35. Horn JL. A rationale and test for the number of factors in factor analysis.
Psychometrika. 1965;30:179–85.
36. Ramp M, Khan F, Misajon RA, Pallant JF. Rasch analysis of the multiple
sclerosis impact scale (MSIS-29). Health Qual Life Outcomes. 2009;7:58.
37. Ajzen I. The theory of planned behavior. Organ Behav Hum Decis Process.
1991;50:179–211.
38. Lagomasino IT, Zatzick DF, Chambers DA. Efficiency in mental health
practice and research. Gen Hosp Psychiatry. 2010;32:477–83.
39. Dickson PR, Ginter JL. Market segmentation, product differentiation, and
marketing strategy. J Mark. 1987;51:1–10.
40. Saldana L. The stages of implementation completion for evidence-based
practice: protocol for a mixed methods study. Implement Sci. 2014;9:43.
Moullin et al. Implementation Science  (2018) 13:89 Page 10 of 10
